Large study co-led by Geisel professor Christopher Amos, PhD, identified several new variants for lung cancer risk that will translate into improved understanding of the mechanisms involved in lung cancer risk.
Konstantin Dragnev, MD, a practicing oncologist at the Dartmouth-Hitchcock Norris Cotton Cancer Center and a translational scientist, has been named the Irene Heinz Given Professor in Pharmacology.
Pre-school age children who are exposed to child-targeted fast-food advertising on television are considerably more likely to consume fast-food products, according to a recent Dartmouth-led study published in the journal Public Health Nutrition.
A new Dartmouth study shows that travel time is not a deterrent to radiation therapy for treatment of prostate cancer in New Hampshire.
Research published in the journal Nature Communications describes distribution of a DNA defect in the glioblastoma genome and its relationship with patient survival.
Young people across the United States who smoke electronic cigarettes are considerably more likely to start smoking traditional cigarettes within a year than their peers who do not smoke e-cigarettes, according to an analysis led by the University of Pittsburgh and Dartmouth.
Gazette Review – A new study coming out of Dartmouth is showing that television food commercials are stimulating the brains of overweight teenagers more than any other group of people.
Investigators from Dartmouth’s Norris Cotton Cancer Center found teens aged 15-17 years old who had ever mixed alcohol with energy drinks were four times more likely to meet the criteria for alcohol use disorder than a teen who has tried alcohol but never mixed it with an energy drink.
A new randomized clinical trial with Dartmouth investigators has noted significant improvement in several measures among those who began palliative care early.
A neuro-oncology research team at Dartmouth’s Norris Cotton Cancer Center, led by the Director Mark A. Israel, MD with first author Gilbert J. Rahme, PhD, recently identified the transcription factor Id4 as a suppressor of tumor cell invasion in glioblastoma.